Jupiter Life Line Hospitals (JLHL) Q1 24/25 earnings summary

Executive summary

• Q1 FY25 saw strong operational and financial performance, with all three hospitals receiving NABH Digital Health - Gold Standard accreditation and expanding robotic surgery offerings, including the addition of da Vinci systems.

• Revenue from operations grew 18.2% year-over-year to ₹284.5 crore in Q1FY25, driven by increased patient volumes and occupancy across three hospitals.

• Expansion projects are progressing, with 22 new beds commissioned in Pune and construction underway for 75 additional beds in Indore, expected to be operational by Q1 FY26.

• Construction of the Dombivli hospital is on track, and regulatory approvals for new Pune land are expected within 6-8 months.

• Unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, were approved by the Board on August 9, 2024.

Financial highlights

• Total income for Q1 FY25 was ₹288.6 crore, up 18.2% year-over-year.

• EBITDA reached ₹65.3 crore, a 21% increase year-over-year, with a margin of 22.6%.

• PAT was ₹44.6 crore, down 17% year-over-year due to a one-time deferred tax benefit in Q1FY24.

• Average occupancy improved to 63.9% from 57.2% in Q1 FY24.

• ARPOB for the quarter was ₹59,700, and ALOS was 3.76 days.

Outlook and guidance

• Growth in the next 1–2 years will be driven by increased occupancy and capacity in Pune and Indore, with further expansion planned in Dombivli and a second Pune hospital.

• Management expects margins around 25% as new hospitals mature over the next three years.

• No immediate plans for self-payer price hikes; potential adjustments may occur at year-end or early next year.

• 75 new beds are being added at Indore Hospital, expected to be operational by Q1FY26.

• 22 new beds were added at Pune Hospital, operational from July 1, 2024.